Skip Navigation

Cardiovascular Research 2002 54(3):684-693; doi:10.1016/S0008-6363(02)00276-6
© 2002 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Altavilla, D.
Right arrow Articles by Squadrito, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Altavilla, D.
Right arrow Articles by Squadrito, F.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 2002, European Society of Cardiology

Inhibition of nuclear factor-{kappa}B activation by IRFI 042, protects against endotoxin-induced shock

Domenica Altavillaa, Giovanni Squadritob,*, Letteria Minutolia, Barbara Deodatoa, Antonino Bovaa, Aurora Sardellaa, Paolo Seminaraa, Maria Passanitia, Giuseppe Urnac, Saverio F Venutid, Achille P Caputia and Francesco Squadritoa

aDepartment of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology School of Medicine, University of Messina, Torre Biologica, Azienda Ospedaliera Universitaria ‘G Martino’, Via C. Valeria, Gazzi, 98125 Messina, Italy
bDepartment of Internal Medicine, University of Messina, Messina, Italy
cDepartment of Physiology and Pharmacology, University of Messina, Messina, Italy
dDepartment of Neurosciences, Psychiatry and Anesthesiology, University of Messina, Messina, Italy

francesco.squadrito{at}unime.it

* Corresponding author. Tel.: +39-90-221-3648; fax: +39-90-221-3300

Background: The aim of our study was to investigate the effect of IRFI 042, a novel dual vitamin E-like antioxidant, on nuclear factor-{kappa}B (NF-{kappa}B) activation, TNF-{alpha} gene priming and on the release of the mature protein during endotoxin shock. Methods: Endotoxin shock was produced in male rats by a single intravenous (i.v.) injection of 20 mg kg–1 of Salmonella enteritidis lipopolysaccharide (LPS). Survival rate, mean arterial blood pressure, serum TNF-{alpha} and plasma malondialdehyde (MAL) levels were investigated. We then evaluated in the liver TNF-{alpha} mRNA levels, NF-{kappa}B binding activity and the inhibitory protein I{kappa}B{alpha}. Moreover we studied in LPS stimulated (50 µg ml–1) peritoneal macrophages (M{varphi}), NF-{kappa}B activation, cytoplasmic I{kappa}B-{alpha} degradation, the message for TNF-{alpha}, and TNF-{alpha} and MAL levels. Results: LPS administration reduced survival rate (0%, 72 h after LPS administration), decreased mean arterial blood pressure, augmented serum TNF-{alpha} (60±11 ng ml–1) and enhanced plasma malondialdehyde (MAL) levels (55±7.1 nmol l–1). LPS shocked rats also had increased TNF-{alpha} mRNA levels, augmented liver NF-{kappa}B binding activity in the nucleus and decreased levels of the inhibitory protein I{kappa}B{alpha}. In addition, in vitro LPS stimulation (50 µg ml–1) significantly induced NF-{kappa}B activation and cytoplasmic I{kappa}B{alpha} degradation in M{varphi}, enhanced TNF-{alpha} mRNA levels and increased M{varphi} TNF-{alpha} and MAL. Treatment with IRFI 042 (20 mg kg–1, i.v., 5 min after endotoxin challenge) protected against LPS-induced lethality (90% survival rate 24 h and 80% survival rate 72 h after LPS injection, respectively), reduced hypotension, blunted plasma MAL (9.0±0.9 nmol l–1) and decreased serum TNF-{alpha} (15±3 ng ml–1). The antioxidant also inhibited the loss of I{kappa}B{alpha} protein from the hepatic cytoplasm, blunted the increased NF-{kappa}B binding activity in the liver and decreased hepatic liver mRNA for TNF-{alpha}. Furthermore ‘in vitro’ IRFI 042 (50 µM) significantly inhibited activation of NF-{kappa}B through inhibition of I{kappa}B{alpha} degradation, reduced the amount of TNF-{alpha} mRNA, decreased LPS-induced TNF-{alpha} release and blunted lipid peroxidation (MAL) in LPS stimulated M{varphi}. Conclusions: These data suggest that IRFI 042 blocks the activation of NF-{kappa}B, reduces TNF-{alpha} mRNA levels, and finally reverses endotoxic shock.

KEYWORDS Cytokines; Endotoxins; Free radicals; Gene expression; Macrophages; Septic shock; Signal transduction


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
J. Ding, D. Song, X. Ye, and S. F. Liu
A Pivotal Role of Endothelial-Specific NF-{kappa}B Signaling in the Pathogenesis of Septic Shock and Septic Vascular Dysfunction
J. Immunol., September 15, 2009; 183(6): 4031 - 4038.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. H. Kim, E. Roh, H. Y. Lee, I.-J. Lee, B. Ahn, S.-H. Jung, H. Lee, S.-B. Han, and Y. Kim
Benzoxathiole Derivative Blocks Lipopolysaccharide-Induced Nuclear Factor-{kappa}B Activation and Nuclear Factor-{kappa}B-Regulated Gene Transcription through Inactivating Inhibitory {kappa}B Kinase {beta}
Mol. Pharmacol., April 1, 2008; 73(4): 1309 - 1318.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Chatterjee, C. Dimitropoulou, F. Drakopanayiotakis, G. Antonova, C. Snead, J. Cannon, R. C. Venema, and J. D. Catravas
Heat Shock Protein 90 Inhibitors Prolong Survival, Attenuate Inflammation, and Reduce Lung Injury in Murine Sepsis
Am. J. Respir. Crit. Care Med., October 1, 2007; 176(7): 667 - 675.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. F. Liu and A. B. Malik
NF-{kappa}B activation as a pathological mechanism of septic shock and inflammation
Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L622 - L645.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Messina, D. Altavilla, M. Aguennouz, P. Seminara, L. Minutoli, M. C. Monici, A. Bitto, A. Mazzeo, H. Marini, F. Squadrito, et al.
Lipid Peroxidation Inhibition Blunts Nuclear Factor-{kappa}B Activation, Reduces Skeletal Muscle Degeneration, and Enhances Muscle Function in mdx Mice
Am. J. Pathol., March 1, 2006; 168(3): 918 - 926.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Marsik, M. Graninger, N. Mackman, B. Osterud, T. Luther, and B. Jilma
Effects of enalapril on disseminated intravascular thrombin formation during systemic inflammation
Cardiovasc Res, October 15, 2003; 60(1): 131 - 135.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.